We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.20 | -2.67% | 7.30 | 7.00 | 7.60 | 7.55 | 7.30 | 7.55 | 651,480 | 11:46:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.16 | 43.82M |
TIDMKMK
RNS Number : 3653R
Kromek Group PLC
10 September 2014
10 September 2014
Kromek Group plc
("Kromek" or "the Company")
Annual Report and Accounts and Notice of AGM
Kromek (AIM: KMK.L), a supplier of patented radiation detection technologies to the medical, security and nuclear markets, announces that its Annual General Meeting will be held at 10:00am on 1st October 2014 at the Company's head office, NETPark, Thomas Wright Way, Sedgefield, County Durham, TS21 3FD.
The Company's annual report and accounts for the year ended 30 April 2014 and its AGM notice have been posted to shareholders and copies are available from the Company's website www.kromek.com.
-Ends-
For further information, please contact:
Kromek Group plc Tel: 01740 626060 Arnab Basu, CEO Derek Bulmer, CFO Panmure Gordon Tel: 020 7886 2500 As Nominated Adviser and Broker Corporate Finance Freddy Crossley Broking Charles Leigh-Pemberton Tavistock Communications Tel: 020 7920 3150 Matt Ridsdale Andrew Dunn
About Kromek Group plc
Kromek Group plc is a UK technology company (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT"). Using its core CZT technology Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.
The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.
Kromek uses multiple technologies in its manufacturing processes, including the established methods of 'liquid phase' detector production, and also 'vapour phase' production methods, which allow the production of high quality, high performance detectors on an industrial scale. Kromek has an intellectual property portfolio of more than 250 pieces of IP.
The Group's business model provides a vertically integrated technology offering to customers, from the growth of CZT crystals to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").
The Board believes that the vertical integration offered by Kromek, combined with the benefit of 25 years of research into CZT production and the patents and trade secrets accumulated by the Group, are unparalleled in the market place.
The Group has operations in the UK, Germany and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.
Currently, the Group has over a hundred full time employees across its global operations.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLMMFTMBIBBAI
1 Year Kromek Chart |
1 Month Kromek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions